These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8386553)

  • 1. Bone-derived growth factor release from poly(alpha-hydroxy acid) implants in vitro.
    Meikle MC; Mak WY; Papaioannou S; Davies EH; Mordan N; Reynolds JJ
    Biomaterials; 1993 Feb; 14(3):177-83. PubMed ID: 8386553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit.
    Meikle MC; Papaioannou S; Ratledge TJ; Speight PM; Watt-Smith SR; Hill PA; Reynolds JJ
    Biomaterials; 1994 Jun; 15(7):513-21. PubMed ID: 7918904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material.
    Elgendy HM; Norman ME; Keaton AR; Laurencin CT
    Biomaterials; 1993; 14(4):263-9. PubMed ID: 8386557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scanning electron microscopic study of cell attachment to biodegradable polymer implants.
    Zislis T; Mark DE; Cerbas EL; Hollinger JO
    J Oral Implantol; 1989; 15(3):160-7. PubMed ID: 2561760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
    Benoit MA; Mousset B; Delloye C; Bouillet R; Gillard J
    Int Orthop; 1997; 21(6):403-8. PubMed ID: 9498152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scanning electron microscopic study of in vitro toxicity of ethylene-oxide-sterilized bone repair materials.
    Zislis T; Martin SA; Cerbas E; Heath JR; Mansfield JL; Hollinger JO
    J Oral Implantol; 1989; 15(1):41-6. PubMed ID: 2561372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gel casting of resorbable polymers. 2. In-vitro degradation of bone graft substitutes.
    Coombes AG; Heckman JD
    Biomaterials; 1992; 13(5):297-307. PubMed ID: 1600032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2).
    Hile DD; Amirpour ML; Akgerman A; Pishko MV
    J Control Release; 2000 May; 66(2-3):177-85. PubMed ID: 10742578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous-coated titanium implant impregnated with a biodegradable protein delivery system.
    Agrawal CM; Pennick A; Wang X; Schenck RC
    J Biomed Mater Res; 1997 Sep; 36(4):516-21. PubMed ID: 9294767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer.
    Isobe M; Yamazaki Y; Oida S; Ishihara K; Nakabayashi N; Amagasa T
    J Biomed Mater Res; 1996 Nov; 32(3):433-8. PubMed ID: 8897149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidity near eroding polylactide-polyglycolide in vitro and in vivo in rabbit tibial bone chambers.
    Martin C; Winet H; Bao JY
    Biomaterials; 1996 Dec; 17(24):2373-80. PubMed ID: 8982478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoroughness, Surface Chemistry, and Drug Delivery Control by Atmospheric Plasma Jet on Implantable Devices.
    Patelli A; Mussano F; Brun P; Genova T; Ambrosi E; Michieli N; Mattei G; Scopece P; Moroni L
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39512-39523. PubMed ID: 30359523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased fibroblast cell density on chemically degraded poly-lactic-co-glycolic acid, polyurethane, and polycaprolactone.
    Vance RJ; Miller DC; Thapa A; Haberstroh KM; Webster TJ
    Biomaterials; 2004 May; 25(11):2095-103. PubMed ID: 14741624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
    Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro.
    Wake MC; Gerecht PD; Lu L; Mikos AG
    Biomaterials; 1998 Jul; 19(14):1255-68. PubMed ID: 9720889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration.
    Gombotz WR; Pankey SC; Bouchard LS; Ranchalis J; Puolakkainen P
    J Biomater Sci Polym Ed; 1993; 5(1-2):49-63. PubMed ID: 8297831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymeric reservoir.
    Yamazaki Y; Oida S; Ishihara K; Nakabayashi N
    J Biomed Mater Res; 1996 Jan; 30(1):1-4. PubMed ID: 8788099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.